Privacy Policy

Pharma Watchdog and Potts Sadaka LLC is committed to protecting your privacy. It is also our goal to constantly improve our services to you and to keep up with rapidly changing technologies. In order to maximize our services to you, we use information collected about you while still protecting your privacy. Expecting future variations in our service, these policies are subject to change. If there are any modifications to these policies, we will post them on this page and notify you as described at the end of this policy.

I. Security Measures Concerning Your Personal Information

We take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline.

II. Information Collection, Use, and Sharing

We are the sole owners of the information collected on these sites. We only have access to/collect information that you voluntarily give us via email or other direct contact from you. We will not sell or rent this information to anyone.

We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization, other than as necessary to fulfill your request, e.g. to ship an order.

Unless you ask us not to, we may contact you via email in the future to tell you about specials, new products or services, or changes to this privacy policy.

III. Control Over Information

You may opt out of any future contacts from us at any time. You can do the following at any time by contacting us via the email address or phone number given on our website:

See what data we have about you, if any.
Change/correct any data we have about you.
Have us delete any data we have about you.
Express any concern you have about our use of your data.

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Heightened Thrombosis Risk with Birth Control Patch and Ring

A BMJ study has found more evidence that women using the transdermal contraceptive patch or vaginal ring do indeed face higher thrombosis risks than those taking their contraceptive orally. Using Danish national registries, researchers studied over 1.5 million women without prior thrombotic disease or cancer, who were not pregnant. Overall, the incidence of venous thrombosis [...]

Is Your Heartburn Medication Putting You At Risk?

According to a new study, your heartburn medication could be putting you at risk for a nasty stomach bug! The infection, Clostridium difficile infection, also called C. difficile or CDI, is a hard-to-cure infection that causes severe diarrhea that has recently been linked to proton pump inhibitors (PPIs), the most powerful class of antacid drugs. [...]

Cipralex and Abnormal Heart Rhythms

Health Canada is informing Canadians of a labeling update for the prescription drug Cipralex (Escitalopram) regarding a dose-related risk of abnormal heart rhythms. The risk is dose-related, 20 mg per day is still the maximum recommended dose for most patients. Before starting Cipralex, talk to your healthcare professional. If you have had any heart problems, what other medications you [...]

Florida Compounding Pharmacy Linked To Rare Fungal Eye Infections

Whats that in my eye?! Thirty-three cases of a rare, but serious, fungal eye infection have been confirmed across seven states. Federal officials are announcing that the infection stemmed from products mixed in a Florida compounding pharmacy. it seems the victims underwent some sort of an eye procedure, either a surgery or injections. Of these, [...]

Multaq and Death By Heart Problems

Multaq, also known as Dronedarone, is used to treat heart patients that had atrial fibrillation, which is a rhythm disorder that could make the heart beat fast and irregular. It’s also used to treat atrial flutter, which also causes the heart to beat fast, but is still considered regular. However, this drug is known to [...]

Latest Medical Device Injury News

More Sufferers File Lawsuits Against DePuy Orthopaedics

Two more people who’ve suffered serious injuries blamed on the defective and recalled DePuy Orthopaedics ASR hip implant are the latest to join a growing federal class-action lawsuit against the medical device firm and its parent company, Johnson & Johnson. The plaintiff’s are being represented by the law firm of Parker Waichman LLP and are [...]

Metal-on-Metal Hip Implant Finds No Increased Cancer Risk?

We have written countless articles discussing the dangers of metal-on-metal implants, yet a new study is downplaying the potential dangerous effects, such as the risk of cancer. The recent study was published in the British Medical Journal which analyzed cancer rates among patients with metal-on-metal implants versus patients with other types of implants as well [...]

St. Jude’s Wants Study Retracted Due To Inaccuracy

St. Jude Medical has asked the Heart Rhythm Journal to retract a study published last month that linked its Riata line of internal defibrillator leads to more 20 deaths. In a statement issued by St. Jude, the company asserted the Riata lead study was biased and based on inaccurate facts. According to the Heart Rhythm [...]

Vaginal Mesh Lawsuits Claim Painful Erosion, Organ Damage

An estimated 35,000 women who suffered through bladder control problems brought on by aging, child birth, and a variety of other causes. The lives of those who had adverse reactions to vaginal mesh were literally ruined as many experienced crippling pain and permanent scarring damage from the procedures involved in the insertion and necessary removal of the vaginal mesh.

If you or a loved one suffered vaginal erosion call us immediately at 1-800-810-3457.

FDA Reposts Thoratec HeartMate II LVAS Class I Recall

A recall of Thoratec’s HeartMate II Left Ventricle Assist System (LVAS) that was first announced in February has been designated Class I, the U.S. Food & Drug Administration’s (FDA) most serious type of recall. The HeartMate II LVAS is a heart pump which is used as a bridge to transplantation in heart transplant candidates at [...]